专利号:US-2012177593-A1 优先权日:2009-07-20 标 题 :Synthesis of dendrimer conjugates 发明人:BAKER JR JAMES R; ZHANG YUEHUA; THOMAS THOMMEY P; DESAI ANKUR MAHESH 权利人:BAKER JR JAMES R; ZHANG YUEHUA; THOMAS THOMMEY P; DESAI ANKUR MAHESH; UNIV MICHIGAN 摘要:The present invention relates to novel methods of synthesis of therapeutic and diagnostic dendrimers. In particular, the present invention is directed to novel dendrimer conjugates, novel methods of synthesizing the same, compositions comprising the conjugates, as well as systems and methods utilizing the conjugates (e.g., in diagnostic and/or therapeutic settings (e.g., for the delivery of therapeutics, imaging, and/or targeting agents (e.g., in disease (e.g., cancer, inflammatory disease) diagnosis and/or therapy, pain therapy, etc.)). Accordingly, dendrimer conjugates of the present invention may further comprise at least two different components for targeting, imaging, sensing, and/or providing a therapeutic or diagnostic material and/or monitoring response to therapy. Furthermore, the novel synthesis methods of certain embodiments of the present invention provide significant advantages with regard to total reaction time and simplicity.
专利号:US-10925977-B2 优先权日:2006-10-05 标 题 :Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications 发明人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S 权利人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S; CEIL POINT LLC; UNIV TEXAS 摘要:Novel methods of synthesis of chelator-targeting ligand conjugates, compositions comprising such conjugates, and therapeutic and diagnostic applications of such conjugates are disclosed. The compositions include chelator-targeting ligand conjugates optionally chelated to one or more metal ions. Methods of synthesizing these compositions in high purity are also presented. Also disclosed are methods of imaging, treating and diagnosing disease in a subject using these novel compositions, such as methods of imaging a tumor within a subject and methods of diagnosing myocardial ischemia.
专利号:US-10973847-B2 优先权日:2017-06-30 标题 :Core-to-surface polymerization for the synthesis of star polymers and uses thereof 发明人:JOHNSON JEREMIAH A; GOLDER MATTHEW R 权利人:MASSACHUSETTS INST TECHNOLOGY 摘要:Disclosed are methods, compositions, reagents, systems, and kits to prepare star polymers, as well as compositions and uses thereof. Various embodiments show that synthesis of these polymers contain low metal concentration to provide polymers for diverse biomedical applications including in vivo applications.
专利号:WO-2004089946-A1 优先权日:2003-04-07 标题:Microwave synthesis of mycophenolate 发明人:ADHIKARY LAXMI; SURYANARAYAN SHRIKUMAR 权利人:BIOCON LTD; ADHIKARY LAXMI; SURYANARAYAN SHRIKUMAR 摘要:A process for synthesis of a compound of formula (I) using microwave irradiation.
专利号:US-2025236876-A1 优先权日:2024-01-22 标题:Engineered yeast for efficient and rapid synthesis of erythritol and construction method thereof 发明人:CHENG HAIRONG; XU SHUO 权利人:UNIV SHANGHAI JIAOTONG 摘要:Disclosed are an engineered yeast for efficient and rapid synthesis of erythritol and a construction method thereof. Yarrowia lipolytica is used as a synthetic chassis for genetic improvement. A method for synthesizing erythritol is as follows: using glucose as a carbon source, and a nitrogen source and an inorganic salt as raw materials, sterilizing a medium, cooling the sterilized medium before inoculating yeast Yarrowia lipolytica , performing continuous fermentation or fed-batch fermentation under the condition of oxygen supply, and purifying erythritol from a fermentation broth. Under the condition of continuous feeding, the yield of erythritol is more than 350 g/L, and the production efficiency is more than 4.5 g/L·h, nearly 100% higher than that of a comparative strain.
专利号:US-12391691-B2 优先权日:2018-11-16 标题:Synthesis of key intermediate of KRAS G12C inhibitor compound 发明人:PARSONS ANDREW THOMAS; COCHRAN BRIAN MCNEIL; POWAZINIK IV WILLIAM; CAPORINI MARC ANTHONY 权利人:AMGEN INC 摘要:The present invention relates to an improved, efficient, scalable process to prepare intermediate compounds, such as compound 5M, having the structure n nuseful for the synthesis of compounds that target KRAS G12C mutations, such as
1: Berti A, Scotti R, Rizzo N, Sabbadini MG, Tresoldi M. Kaposi's Sarcoma in a Patient with Eosinophilic Granulomatosis with Polyangiitis While Taking Mycophenolate Mofetil. J Allergy Clin Immunol Pract. 2015 May-Jun;3(3):431-2. doi: 10.1016/j.jaip.2014.11.023. Epub 2015 Jan 21. Review. Review. Polish. doi: 10.3109/09546634.2014.880395. Epub 2014 Feb 13. Review. doi: 10.1186/1471-2369-15-193. Review. 5: Conti F, Ceccarelli F, Perricone C, Massaro L, Cipriano E, Pacucci VA, Truglia S, Miranda F, Morello F, Alessandri C, Spinelli FR, Valesini G. Mycophenolate mofetil in systemic lupus erythematosus: results from a retrospective study in a large monocentric cohort and review of the literature. Immunol Res. 2014 Dec;60(2-3):270-6. doi: 10.1007/s12026-014-8609-x. Review. doi: 10.1111/tri.12382. Epub 2014 Aug 22. Review. doi: 10.1016/j.crohns.2014.01.014. Epub 2014 Feb 4. Review. doi: 10.1002/14651858.CD010280.pub2. Review. Review. doi: 10.1016/j.leukres.2013.12.012. Epub 2013 Dec 25. Review. doi: 10.1002/14651858.CD010242.pub2. Review. doi: 10.1016/j.trre.2013.10.005. Epub 2013 Oct 25. Review. doi: 10.12659/AOT.889299. Review. doi: 10.1097/TP.0b013e31828c6dc7. Review. doi: 10.3109/0886022X.2013.794687. Epub 2013 May 28. Review. doi: 10.1016/j.ijid.2012.11.005. Epub 2012 Dec 5. Review. doi: 10.1111/nep.12006. Review. Review. Polish. doi: 10.1111/j.1365-2125.2012.04305.x. Review. 20: Hogan J, Schwenk MH, Radhakrishnan J. Should mycophenolate mofetil replace cyclophosphamide as first-line therapy for severe lupus nephritis? Kidney Int. 2012 Dec;82(12):1256-60. doi: 10.1038/ki.2012.203. Epub 2012 May 30. Review.
合成参考文献
参考文献:10.2174/092986710790712174 摘要:Ulinski T, Aoun B. Pediatric idiopathic nephrotic syndrome: treatment strategies in steroid dependent and steroid resistant forms. Curr Med Chem. 2010;17(9):847–53. doi: 10.2174/092986710790712174. 参考文献:10.1177/0961203309355809 摘要:Habibi S, Agrawal S, Narsimulu G. Mycophenolate: dual utility in rare conditions of HIV infection complicating lupus. Lupus. 2010 May;19(6):774–5. doi: 10.1177/0961203309355809. 参考文献:10.1111/j.1478-3231.2011.02563.x 摘要:Saner FH, Cicinnati VR, Sotiropoulos G, Beckebaum S. Strategies to prevent or reduce acute and chronic kidney injury in liver transplantation. Liver Int. 2012 Feb;32(2):179–88. doi: 10.1111/j.1478-3231.2011.02563.x. 参考文献:10.1016/j.bbmt.2011.06.014 摘要:Cao W, Xiao H, Lai X, Luo Y, Shi J, Tan Y, Zheng W, He J, Xie W, Li L, Ye X, Yu X, Lin M, Cai Z, Huang H. Genetic variations in the mycophenolate mofetil target enzyme are associated with acute GVHD risk after related and unrelated hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2012 Feb;18(2):273–9. doi: 10.1016/j.bbmt.2011.06.014. 参考文献:10.1007/s12185-011-0888-6 摘要:Wakahashi K, Yamamori M, Minagawa K, Ishii S, Nishikawa S, Shimoyama M, Kawano H, Kawano Y, Kawamori Y, Sada A, Matsui T, Katayama Y. Pharmacokinetics-based optimal dose prediction of donor source-dependent response to mycophenolate mofetil in unrelated hematopoietic cell transplantation. International Journal of Hematology. 2011 Jul 14;94(2):193–202. doi: 10.1007/s12185-011-0888-6.